BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10514481)

  • 1. Oncogenic Ras sensitizes cells to apoptosis by Par-4.
    Nalca A; Qiu SG; El-Guendy N; Krishnan S; Rangnekar VM
    J Biol Chem; 1999 Oct; 274(42):29976-83. PubMed ID: 10514481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis.
    Diaz-Meco MT; Lallena MJ; Monjas A; Frutos S; Moscat J
    J Biol Chem; 1999 Jul; 274(28):19606-12. PubMed ID: 10391896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3.
    Chendil D; Das A; Dey S; Mohiuddin M; Ahmed MM
    Cancer Biol Ther; 2002; 1(2):152-60. PubMed ID: 12170775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation.
    Qiu SG; Krishnan S; el-Guendy N; Rangnekar VM
    Oncogene; 1999 Nov; 18(50):7115-23. PubMed ID: 10597313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
    Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
    Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation.
    Finco TS; Westwick JK; Norris JL; Beg AA; Der CJ; Baldwin AS
    J Biol Chem; 1997 Sep; 272(39):24113-6. PubMed ID: 9305854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.
    Dajee M; Lazarov M; Zhang JY; Cai T; Green CL; Russell AJ; Marinkovich MP; Tao S; Lin Q; Kubo Y; Khavari PA
    Nature; 2003 Feb; 421(6923):639-43. PubMed ID: 12571598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.
    Chakraborty M; Qiu SG; Vasudevan KM; Rangnekar VM
    Cancer Res; 2001 Oct; 61(19):7255-63. PubMed ID: 11585763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-Ras-specific activation of NF-kappaB protects NIH 3T3 cells against stimulus-dependent apoptosis.
    Millán O; Ballester A; Castrillo A; Oliva JL; Través PG; Rojas JM; Boscá L
    Oncogene; 2003 Jan; 22(4):477-83. PubMed ID: 12555061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways.
    Norris JL; Baldwin AS
    J Biol Chem; 1999 May; 274(20):13841-6. PubMed ID: 10318790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression.
    Camandola S; Mattson MP
    J Neurosci Res; 2000 Jul; 61(2):134-9. PubMed ID: 10878585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.
    Soares MP; Muniappan A; Kaczmarek E; Koziak K; Wrighton CJ; Steinhäuslin F; Ferran C; Winkler H; Bach FH; Anrather J
    J Immunol; 1998 Nov; 161(9):4572-82. PubMed ID: 9794384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B.
    Folgueira L; Algeciras A; MacMorran WS; Bren GD; Paya CV
    J Virol; 1996 Apr; 70(4):2332-8. PubMed ID: 8642660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IKK beta is required for Bcl-2-mediated NF-kappa B activation in ventricular myocytes.
    Regula KM; Ens K; Kirshenbaum LA
    J Biol Chem; 2002 Oct; 277(41):38676-82. PubMed ID: 12167626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of NF-kappaB in Ki-ras-transformed prostate epithelial cells.
    Kim BY; Gaynor RB; Song K; Dritschilo A; Jung M
    Oncogene; 2002 Jul; 21(29):4490-7. PubMed ID: 12085227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downstream effectors of oncogenic ras in multiple myeloma cells.
    Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
    Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells.
    Pruitt K; Ulkü AS; Frantz K; Rojas RJ; Muniz-Medina VM; Rangnekar VM; Der CJ; Shields JM
    J Biol Chem; 2005 Jun; 280(24):23363-70. PubMed ID: 15831492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
    Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
    Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins.
    Su F; Schneider RJ
    J Virol; 1996 Jul; 70(7):4558-66. PubMed ID: 8676482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.